Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Carboxylic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103687489A reveals a safer, scalable route for 5-azaspiro[2.4]heptane-6-carboxylic acid, eliminating pyrophoric reagents for reliable HCV inhibitor supply.
Novel salt formation method removes dicarboxylic acid impurity ensuring high purity and yield for scalable antihypertensive drug manufacturing.
Patent CN116675671A details high-yield amide synthesis suppressing by-products for cost reduction in agrochemical intermediate manufacturing and supply chain reliability.
Patent CN102317248A details an efficient route for (S)-3-cyclohexene-1-carboxylic acid, a key FXa inhibitor intermediate, offering significant cost and supply chain advantages.
Novel Pd-Pt-Zn catalyst enables 98% CHDA selectivity. Reduces decarboxylation. Ideal for reliable fine chemical intermediate supplier partnerships.
Patent CN110878064A reveals a breakthrough synthesis route for febuxostat impurities, boosting total yield from 0.2% to 43% via strategic intermediate sequencing.
Patent CN116120325B reveals a novel preparation method for Ketorolac EP Impurity D with high purity and simplified operations for reliable pharmaceutical intermediates supply chains.
Novel synthesis route for high-purity pharmaceutical intermediates. Safe scale-up and cost reduction for global supply chains ensuring reliable procurement.
Patent CN110903240A reveals a mild ester-hydrolysis route for cabozantinib, offering high purity and reduced environmental impact for pharmaceutical intermediate manufacturing.
Patent CN1247539C details a high-yield route for chiral beta-lactams, offering simplified purification and industrial scalability for API manufacturers.
Patent CN1125808C reveals a novel metal alkoxide-catalyzed transesterification process for high-purity dicarboxylic acid monoesters, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN111068789A details a novel Ru/Ir catalyst system converting olefins and CO2 into high-value esters, offering safer greener manufacturing.
Patent CN115772143B reveals a green Bi-Pt catalytic method for FDCA synthesis eliminating alkaline waste and reducing processing complexity for bio-based polymer manufacturers.
Patent CN116376872A reveals high-efficiency esterase mutants for (S)-3-cyclohexene-1-carboxylic acid, offering cost reduction and scalable biocatalysis for anticoagulant manufacturing.
Novel pre-alkoxylation route for pyridine-2,3-dicarboxylic acid derivatives via patent CN107759516B. Offers cost reduction in herbicide manufacturing and scalable supply chain solutions.
Novel peptide coupling method ensures high purity Nebivolol intermediate with reduced racemization risks for scalable pharmaceutical manufacturing.
Discover an efficient 3-step synthesis for 1-Boc-3-fluoroazetidine-3-carboxylic acid. This patent offers high yield and scalable production for API manufacturing.
Novel lipase mutant enables efficient synthesis of chiral intermediates. Reduces solvent use and enhances supply chain reliability for global pharmaceutical manufacturing.
Novel solvent-free and solution-based processes for alpha-hydroxy amides. Enhances supply chain reliability and reduces manufacturing costs for fungicide intermediates.
Patent CN1639096A reveals a high-yield isomerization process for trans-isomers. Enhances purity and reduces costs for NPYY5 antagonist manufacturing.